Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Helena C. Maltezou, Sofoklis Stavros, George Asimakopoulos, Vasilios Pergialiotis, Vasilios Raftopoulos, Michael A. Talias, Androula Pavli, George Daskalakis, Michael Sindos, Pelopidas Koutroumanis, Marianna Theodora, Panagiotis Antsaklis, Evangelos Kostis, Evangelia Stratiki, Athanasios Kossyvakis, Maria Theodoridou, Andreas Mentis, Petros Drakakis, Dimitrios Loutradis & Alexandros Rodolakis. (2022) Effectiveness of maternal vaccination with quadrivalent inactivated influenza vaccine in pregnant women and their infants in 2019-2020. Expert Review of Vaccines 21:7, pages 983-992.
Read now
Read now
Yang He, Yi Ding, Bo Cao, Yi Huang & Xiao Wang. (2021) COVID-19 vaccine development from the perspective of cancer patients. Human Vaccines & Immunotherapeutics 17:10, pages 3281-3287.
Read now
Read now
Helena C. Maltezou & Alexandros Rodolakis. (2021) Vaccination of pregnant women against influenza: what is the optimal timing?. Human Vaccines & Immunotherapeutics 17:8, pages 2723-2727.
Read now
Read now
Articles from other publishers (34)
A. Prezzi, X. Saelens & D. Vandijck. (2023) Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence. Virology Journal 20:1.
Crossref
Crossref
Zhenzhen Liu, Yongzhuang Ge, Lixia Ding, Zhongmou Zhang, Ying Qu, Chengyun Jin, Xiao-Na Wang & Zhenya Wang. (2023) Synthesis and evaluation of alkoxy-substituted enamides against influenza A virus in vitro and in vivo. Bioorganic Chemistry 139, pages 106712.
Crossref
Crossref
Huong Le, Nicholas de Klerk, Christopher C Blyth, Heather Gidding, Parveen Fathima & Hannah C Moore. (2023) Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data. Vaccine 41:34, pages 5029-5036.
Crossref
Crossref
Junhao Luo, Zhuohan Zhang, Song Zhao & Rongbao Gao. (2023) A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19. International Journal of Molecular Sciences 24:7, pages 6369.
Crossref
Crossref
Mark R. Opp. (2023) Sleep: Not getting enough diminishes vaccine responses. Current Biology 33:5, pages R192-R194.
Crossref
Crossref
Jindong Gao, Yan Li, Qiyun Xie, Mayasar I. Al-zaban, Fatimah A. Al-Saeed, Ali A. Shati, Amin A. Al-Doaiss, Ahmed Ezzat Ahmed, Shah Nawaz, Hala Ebrahem, Irfan Irshad, Muhammad Fakhar-e-Alam Kulyar & Jiakui Li. (2023) Epidemiological Investigation of Feline Upper Respiratory Tract Infection Encourages a Geographically Specific FCV Vaccine. Veterinary Sciences 10:1, pages 46.
Crossref
Crossref
Helena C. Maltezou, Maria N. Gamaletsou, Dimitra-Maria Koukou, Theodoros V. Giannouchos, Flora Sourri, Natalia Syrimi, Amalia Karapanou, Nikolaos Lemonakis, Emmanuela Peskelidou, Konstantina Papanastasiou, Periklis Panagopoulos, Kyriakos Souliotis, Athanasia Lourida, Dimitrios Hatzigeorgiou & Nikolaos V. Sipsas. (2022) Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study. Vaccine 40:52, pages 7660-7666.
Crossref
Crossref
Irfan A. Rather, Majid Rasool Kamli, Jamal S. M. Sabir & Sajad Ali. (2022) Evaluation of Lactiplantibacillus plantarum KAU007 against Low-Pathogenic Avian Influenza Virus (H9N2). Pathogens 11:11, pages 1246.
Crossref
Crossref
Sean A. Nelson, Katherine A. Richards, Maryah A. Glover, Francisco A. Chaves, Michelle C. Crank, Barney S. Graham, Masaru Kanekiyo & Andrea J. Sant. (2022) CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines. npj Vaccines 7:1.
Crossref
Crossref
Tiantian Mao, Deyu Yan, Mengdi Zhou, Tianyi Qiu & Zhiwei Cao. (2022) Possibility of estimating future mutants for influenza: Comparison between previous prediction and subsequent years observation. Frontiers in Microbiology 13.
Crossref
Crossref
Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, Ioanna Lialliou, Despina Athanasopoulou, Zoi Haila, Areti Kyrimi, Ioanna Giannopoulou, Styliani Giannousa, Maria Pseimada, Olympia Christofilea, George Dounias, Sophocles Lanitis & Eirini Kremasmenou. (2022) Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection. Vaccine 40:40, pages 5752-5756.
Crossref
Crossref
Helena C. Maltezou, George Dounias, Venerando Rapisarda & Caterina Ledda. (2022) Vaccination policies for healthcare personnel: Current challenges and future perspectives. Vaccine: X 11, pages 100172.
Crossref
Crossref
Yulia Desheva, Galina Leontieva, Tatiana Kramskaya, Igor Losev, Andrey Rekstin, Nadezhda Petkova, Polina Kudar & Alexander Suvorov. (2022) Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice. Microorganisms 10:6, pages 1150.
Crossref
Crossref
C.A. Arce-Salinas, Y.N. Esquivel-Torruco, A.A. Bejarano-Juvera, A.K. Bustamante-Flores, N. Aguilar-Martínez, J.G. Azcorra-López, B. Cabañas-Espinosa, E.M. Luna-Rivera, A. Hernández-Alarcón & J. Reyna Figueroa. (2022) Association between influenza vaccination and mortality due to COVID-19. Vacunas (English Edition) 23:2, pages 113-118.
Crossref
Crossref
C.A. Arce-Salinas, Y.N. Esquivel-Torruco, A.A. Bejarano-Juvera, A.K. Bustamante-Flores, N. Aguilar-Martínez, J.G. Azcorra- López, B. Cabañas-Espinosa, E.M. Luna-Rivera, A. Hernández-Alarcón & J. Reyna Figueroa. (2022) Asociación entre la vacunación contra influenza y la mortalidad por COVID-19. Vacunas 23:2, pages 113-118.
Crossref
Crossref
Ranmali Kavishna, Tha Yang Kang, Maurizio Vacca, Benson Yen Leong Chua, Hae-Young Park, Peck Szee Tan, Vincent TK Chow, Mireille H Lahoud & Sylvie Alonso. (2022) A single-shot vaccine approach for the universal influenza A vaccine candidate M2e. Proceedings of the National Academy of Sciences 119:13.
Crossref
Crossref
Savannah A Moritzky, Katherine A Richards, Maryah A Glover, Florian Krammer, Francisco A Chaves, David J Topham, Angela Branche, Jennifer L Nayak & Andrea J Sant. (2022) The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History. The Journal of Infectious Diseases.
Crossref
Crossref
Aniruddha Deka & Samit Bhattacharyya. (2022) The effect of human vaccination behaviour on strain competition in an infectious disease: An imitation dynamic approach. Theoretical Population Biology 143, pages 62-76.
Crossref
Crossref
Helena C. Maltezou, Eleni Ioannidou, Koen De Schrijver, Guido François & Antoon De Schryver. (2021) Influenza Vaccination Programs for Healthcare Personnel: Organizational Issues and Beyond. International Journal of Environmental Research and Public Health 18:21, pages 11122.
Crossref
Crossref
Hongrui Cui, Mart CM de Jong, Nancy Beerens, Monique M. van Oers, Qiaoyang Teng, Luzhao Li, Xuesong Li, Qinfang Liu & Zejun Li. (2021) Vaccination with inactivated virus against low pathogenic avian influenza subtype H9N2 does not prevent virus transmission in chickens. Journal of Virus Eradication 7:3, pages 100055.
Crossref
Crossref
Sean A. Nelson, Thamotharampillai Dileepan, Amy Rasley, Marc K. Jenkins, Nicholas O. Fischer & Andrea J. Sant. (2021) Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge. Journal of Virology 95:16.
Crossref
Crossref
Yuqing Li, Dongqi Liu, Yating Wang, Wenquan Su, Gang Liu & Weijie Dong. (2021) The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection. Frontiers in Immunology 12.
Crossref
Crossref
Martin KrsakAndrés F. Henao-MartínezCarlos Franco-Paredes. (2021) COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunology 34:3, pages 130-133.
Crossref
Crossref
Darja Kanduc. (2021) Lack of Molecular Mimicry between Nonhuman Primates and Infectious Pathogens: The Possible Genetic Bases. Global Medical Genetics 08:01, pages 032-037.
Crossref
Crossref
Gil Y. Melmed, David T. Rubin & Dermot P.B. McGovern. (2021) Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic. Gastroenterology 160:3, pages 639-644.
Crossref
Crossref
Thomas N. Vilches, Affan Shoukat, Claudia Pio Ferreira & Seyed M. Moghadas. (2020) Projecting influenza vaccine effectiveness: A simulation study. PLOS ONE 15:11, pages e0241549.
Crossref
Crossref
Brian J Ward, Alexander Makarkov, Annie Séguin, Stéphane Pillet, Sonia Trépanier, Jiwanjeet Dhaliwall, Michael D Libman, Timo Vesikari & Nathalie Landry. (2020) Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials. The Lancet 396:10261, pages 1491-1503.
Crossref
Crossref
Anna R. Connell, Jeff Connell, T. Ronan Leahy & Jaythoon Hassan. (2020) Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?. Frontiers in Immunology 11.
Crossref
Crossref
Giuseppe Lofano, Corey P. Mallett, Sylvie Bertholet & Derek T. O’Hagan. (2020) Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines. npj Vaccines 5:1.
Crossref
Crossref
Katherine A Richards, Ian Shannon, John J Treanor, Hongmei Yang, Jennifer L Nayak & Andrea J Sant. (2020) Evidence That Blunted CD4 T-Cell Responses Underlie Deficient Protective Antibody Responses to Influenza Vaccines in Repeatedly Vaccinated Human Subjects. The Journal of Infectious Diseases 222:2, pages 273-277.
Crossref
Crossref
Andrea L. Herrera, Christopher Van Hove, Mary Hanson, James B. Dale, Rodney K. Tweten, Victor C. Huber, Diego Diel & Michael S. Chaussee. (2020) Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection. PLOS ONE 15:6, pages e0235139.
Crossref
Crossref
Federica Sicca, Donata Martinuzzi, Emanuele Montomoli & Anke Huckriede. (2020) Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement. Vaccine 38:11, pages 2527-2541.
Crossref
Crossref
Ralph A. Tripp & Ultan F. Power. (2019) Original Antigenic Sin and Respiratory Syncytial Virus Vaccines. Vaccines 7:3, pages 107.
Crossref
Crossref
Peiyang Ding, Qianyue Jin, Wen Zhou, Yongxiao Chai, Xiao Liu, Yao Wang, Xinxin Chen, Junqing Guo, Ruiguang Deng, George F. Gao & Gaiping Zhang. (2019) A Universal Influenza Nanovaccine for “Mixing Vessel” Hosts Confers Potential Ability to Block Cross‐Species Transmission. Advanced Healthcare Materials 8:16, pages 1900456.
Crossref
Crossref